Irinotecan hydrochloride

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

2020 clinical trials

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Colorectal neoplasms	D015179	—	—	160	468	128	13	62	744
Neoplasms	D009369	—	C80	188	104	28	1	14	292
Rectal neoplasms	D012004	—	—	34	105	34	3	11	174
Colonic neoplasms	D003110	—	C18	39	87	31	1	9	150
Stomach neoplasms	D013274	EFO_0003897	C16	37	84	20	4	8	141
Neoplasm metastasis	D009362	EFO_0009708	—	34	67	26	2	19	136
Adenocarcinoma	D000230	—	—	39	93	11	1	8	134
Lung neoplasms	D008175	—	C34.90	27	57	9	3	3	89
Small cell lung carcinoma	D055752	—	—	24	48	12	3	5	79
Esophageal neoplasms	D004938	—	C15	15	50	7	1	3	71

Show 7 more

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Pancreatic neoplasms	D010190	EFO_0003860	C25	98	188	41	—	24	302
Recurrence	D012008	—	—	26	33	9	—	3	62
Pancreatic ductal carcinoma	D021441	—	—	22	35	6	—	3	58
Non-small-cell lung carcinoma	D002289	—	—	24	36	1	—	2	54
Neuroblastoma	D009447	EFO_0000621	—	28	30	2	—	—	51
Glioblastoma	D005909	EFO_0000515	—	24	30	3	—	—	48
Sarcoma	D012509	—	—	16	27	5	—	4	45
Breast neoplasms	D001943	EFO_0003869	C50	17	21	1	—	4	41
Esophageal squamous cell carcinoma	D000077277	—	—	9	25	9	—	—	40
Ewing sarcoma	D012512	EFO_0000173	—	17	22	2	—	2	35

Show 54 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Glioma	D005910	EFO_0000520	—	21	27	—	—	—	41
Central nervous system neoplasms	D016543	—	—	18	15	—	—	1	28
Ovarian neoplasms	D010051	EFO_0003893	C56	13	8	—	—	1	20
Astrocytoma	D001254	EFO_0000271	—	11	10	—	—	—	19
Gliosarcoma	D018316	—	—	8	9	—	—	—	16
Triple negative breast neoplasms	D064726	—	—	10	6	—	—	—	15
Nervous system neoplasms	D009423	—	—	8	11	—	—	—	14
Oligodendroglioma	D009837	EFO_0000631	—	7	6	—	—	—	13
Medulloblastoma	D008527	—	—	6	9	—	—	—	12
Lymphoma	D008223	—	C85.9	8	4	—	—	—	12

Show 96 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Precursor cell lymphoblastic leukemia-lymphoma	D054198	—	C91.0	4	—	—	—	1	5
Gastrointestinal stromal tumors	D046152	EFO_0000505	C49.A	5	—	—	—	—	5
Prostatic neoplasms	D011471	—	C61	4	—	—	—	—	4
Large b-cell lymphoma diffuse	D016403	—	C83.3	4	—	—	—	—	4
Castration-resistant prostatic neoplasms	D064129	—	—	3	—	—	—	—	3
Myeloid leukemia acute	D015470	—	C92.0	2	—	—	—	1	3
B-cell chronic lymphocytic leukemia	D015451	—	C91.1	3	—	—	—	—	3
Hodgkin disease	D006689	—	C81	3	—	—	—	—	3
Burkitt lymphoma	D002051	—	C83.7	3	—	—	—	—	3
Large-cell lymphoma immunoblastic	D016400	—	—	3	—	—	—	—	3

Show 51 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Prognosis	D011379	—	—	—	—	—	—	2	2
Lymphoid leukemia	D007945	—	C91	—	—	—	—	1	1
Body weight	D001835	EFO_0004338	—	—	—	—	—	1	1
Hypertension	D006973	EFO_0000537	I10	—	—	—	—	1	1
Chemoradiotherapy	D059248	—	—	—	—	—	—	1	1
Acne vulgaris	D000152	EFO_0003894	L70	—	—	—	—	1	1
Brain death	D001926	—	G93.82	—	—	—	—	1	1
Mucositis	D052016	EFO_1001898	—	—	—	—	—	1	1
Ultrasonic therapy	D014464	—	—	—	—	—	—	1	1
Multiple primary neoplasms	D009378	—	—	—	—	—	—	1	1